• 1
    Nathan C. 1992 Nitric oxide as a secretory product of mammalian cells. FASEB J 6 3051
  • 2
    Bogdan C. 1997 Of microbes, macrophages and nitric oxide. Behring Inst Mitt 99 58
  • 3
    MacMicking J., Xie W.W., Nathan C. 1997 Nitric oxide and macrophage function. Annu Rev Immunol 15 323
  • 4
    Chan J., Tanaka K., Caroll D., Flynn J., Bloom B.R. 1995 Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun 63 736
  • 5
    Flesch I.E. & Kaufmann S.H.E. 1991 Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 59 3213
  • 6
    Liew F.Y., Millott S., Parkinson C., Palmer R.M., Moncada S. 1990 Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from l-arginine. J Immunol 144 4794
  • 7
    MacMicking J.D., North R.J., Lacourse R., Mudgett J.S., Shah S.K., Nathan C. 1997 Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acas Sci USA 94 5243
  • 8
    Stenger S., Donhauser N., Thüring H., Röllinghoff M., Bogdan C. 1996 Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183 1501
  • 9
    Bogdan C. 1998 The multiplex function of nitric oxide in (auto) immunity. J Exp Med 187 1361
  • 10
    Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. 1994 Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis. J Clin Invest 93 2684
  • 11
    Florquin S., Amraoui Z., Dubois C., Decuyper J., Goldman M. 1994 The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 180 1153
  • 12
    Hooper D.C., Bagasra O., Marini J.C. et al. 1997 Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 94 2528
  • 13
    Liew F.Y. 1995 Regulation of lymphocyte functions by nitric oxide. Curr Opin Immunol 7 396
  • 14
    Lyons C.R. 1995 The role of nitric oxide in inflammation. Adv Immunol 60 323
  • 15
    Nussler A.K. & Billiar T.R. 1993 Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 54 171
  • 16
    Belenky S.N., Robbins R.A., Rubinstein I. 1993 Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol 53 498
  • 17
    Setoguchi K., Takeya M., Akaike T. et al. 1996 Expression of inducible nitric oxide synthase and its involvement in pulmonary granulomatous inflammation in rats. Am J Pathol 149 2005
  • 18
    Hickey M.J., Sharkey K.A., Sihota E.G. et al. 1997 Inducible nitric oxide synthase-deficient mice have enhanced leukocyte–endothelium interactions in endotoxemia. FASEB J 11 955
  • 19
    Kubes P., Suzuki M., Granger D.N. 1991 Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88 4651
  • 20
    Fehsel K., Kroncke K.D., Meyer K.L., Huber H., Wahn V., Kolb-Bachofen V. 1995 Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 155 2858
  • 21
    Okuda Y., Sakoda S., Shimaoka M., Ynagihara T. 1996 Nitric oxide induces apoptosis in mouse splenic T lymphocytes. Immunol Lett 52 135
  • 22
    Tomioka H., Sato K., Maw W.W., Saito H. 1995 The role of tumor necrosis factor, interferon-γ, transforming growth factor-β, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection. J Leukoc Biol 58 704
  • 23
    Xiong H., Kawamura I., Nishibori T., Mitsuyama M. 1996 Suppression of IFN-gamma production from Listeria monocytogenes-specific T cells by endogenously produced nitric oxide. Cell Immunol 172 118
  • 24
    Ehlers S. & Seitzer U. 1998 Measuring immune responses in vivo. In: Methods in Microbiology, (eds. S. Kaufmann & D. Kabelitz), vol. 25, p. 365, Academic Press, London.
  • 25
    Tsuji M., Dimov V.B., Yoshida T. 1995 In vivo expression of monokine and inducible nitric oxide synthase in experimentally induced pulmonary granulomatous inflammation: evidence for sequential production of interleukin-1, inducible nitric oxide synthase, and tumor necrosis factor. Am J Pathol 147 1001
  • 26
    Hogaboam C.M., Chensue S.W., Steinhauser M.L. et al. 1997 Alteration of the cytokine phenotype in an experimental lung granuloma model by inhibiting nitric oxide. J Immunol 159 5585
  • 27
    Inderlied C.B., Kemper C.A., Bermudez L.E. 1993 The Mycobacterium avium complex. Clin Microbiol Rev 6 266
  • 28
    Doi T., Ando M., Akaike T., Suga M., Sato K., Maeda H. 1993 Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect Immun 61 1980
  • 29
    Hänsch H.C.R., Smith D.A., Mielke M.E.A., Hahn H., Bancroft G.J., Ehlers S. 1996 Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int Immunol 8 1299
  • 30
    Pedrosa J., Florido M., Kunze Z.M. et al. 1994 Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice. Clin Exp Immunol 98 210
  • 31
    Stenger S., Thüring H., Röllinghoff M., Manning P., Bogdan C. 1995 L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. Eur J Pharmacol 294 703
  • 32
    Kosco-Vilbois M.H., Zentgraf H., Gerdes J., Bonnefoy J.Y. 1997 To ‘B’ or not to ‘B’ a germinal center? Immunol Today 18 225
  • 33
    Appelberg R., Castro A.G., Pedrosa J., Silva R.A., Orme I.M., Minoprio P. 1994 Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Jnfect Immun 62 3962
  • 34
    Smith D.A., Hänsch H., Bancroft G.J., Ehlers S. 1997 T-cell-independent granuloma formation in response to Mycobacterium avium: role of tumour necrosis factor-α and interferon-γ. Immunology 92 413
  • 35
    Flesch I.E., Hess J.H., Huang S. et al. 1995 Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J Exp Med 181 1615
  • 36
    Mills C.D. 1991 Molecular basis of ‘suppressor’ macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 146 2719
  • 37
    Gomes M.S., Florido M., Pais T.F., Appelberg R. 1999 Improved clearance of Mycobacterium avium upon disruption of the inducible nitric oxide synthase gene. J Immunol 162 6734
  • 38
    Iuvone T., Carnuccio R., Dirosa M. 1994 Modulation of granuloma formation by endogenous nitric oxide. Eur J Pharmacol 265 89
  • 39
    Doherty T.M. & Sher A. 1997 Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. J Immunol 158 4822
  • 40
    Appelberg R. & Sarmento A.M. 1990 The role of macrophage activation and of Bcg-encoded macrophage function(s) in the control of Mycobacterium avium infection in mice. Clin Exp Immunol 80 324